256 related articles for article (PubMed ID: 38459552)
21. [Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil].
Yela DA; Monteiro IM; Bahamondes LG; Del Castillo S; Bahamondes MV; Fernandes A
Rev Assoc Med Bras (1992); 2006; 52(1):32-6. PubMed ID: 16622536
[TBL] [Abstract][Full Text] [Related]
22. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
[TBL] [Abstract][Full Text] [Related]
23. Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
Bunjun R; Ramla TF; Jaumdally SZ; Noël-Romas L; Ayele H; Brown BP; Gamieldien H; Harryparsad R; Dabee S; Nair G; Onono M; Palanee-Phillips T; Scoville CW; Heller KB; Baeten JM; Bosinger SE; Burgener A; Passmore JS; Jaspan H; Heffron R
Clin Infect Dis; 2022 Nov; 75(11):2000-2011. PubMed ID: 35941737
[TBL] [Abstract][Full Text] [Related]
24. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
25. Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.
Hapgood JP
AIDS Res Hum Retroviruses; 2020 May; 36(5):357-366. PubMed ID: 31797677
[TBL] [Abstract][Full Text] [Related]
26. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
Anwar M; Soejono SK; Maruo T; Abdullah N
Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
[TBL] [Abstract][Full Text] [Related]
27. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
Naessen T; Olsson SE; Gudmundson J
Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
[TBL] [Abstract][Full Text] [Related]
28. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
Hofmeyr GJ; Singata-Madliki M; Lawrie TA; Bergel E; Temmerman M
Reprod Health; 2016 Apr; 13():42. PubMed ID: 27091008
[TBL] [Abstract][Full Text] [Related]
29. Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception.
Onono M; Nanda K; Heller KB; Taylor D; Yacobson I; Heffron R; Kasaro MP; Louw CE; Nhlabasti Z; Palanee-Phillips T; Smit J; Wakhungu I; Gichangi PB; Mugo NR; Morrison C; Baeten JM;
Contracept X; 2020; 2():100026. PubMed ID: 32577615
[TBL] [Abstract][Full Text] [Related]
30. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
[TBL] [Abstract][Full Text] [Related]
31. Contraceptive Continuation and Experiences Obtaining Implant and IUD Removal Among Women Randomized to Use Injectable Contraception, Levonorgestrel Implant, and Copper IUD in South Africa and Zambia.
Cartwright AF; Callahan RL; Beksinska M; Kasaro MP; Tang JH; Milford C; Wong C; Velarde M; Maphumulo V; Fawzy M; Chinyama M; Chabu E; Mudenda M; Smit J
Stud Fam Plann; 2023 Jun; 54(2):379-401. PubMed ID: 36727169
[TBL] [Abstract][Full Text] [Related]
32. Body weight and body composition of depot medroxyprogesterone acetate users.
Dal'Ava N; Bahamondes L; Bahamondes MV; Bottura BF; Monteiro I
Contraception; 2014 Aug; 90(2):182-7. PubMed ID: 24780631
[TBL] [Abstract][Full Text] [Related]
33. Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate.
Haddad LB; Cwiak C; Jamieson DJ; Feldacker C; Tweya H; Hosseinipour M; Hoffman I; Bryant AG; Stuart GS; Noah I; Mulundila L; Samala B; Mayne P; Phiri S
Contraception; 2013 Dec; 88(6):737-43. PubMed ID: 24060297
[TBL] [Abstract][Full Text] [Related]
34. Genital inflammatory status and the innate immune response to contraceptive initiation.
Radzey N; Harryparsad R; Meyer B; Chen PL; Gao X; Morrison C; Taku O; Williamson AL; Mehou-Loko C; Lefebvre d'Hellencourt F; Buck G; Smit J; Strauss J; Nanda K; Ahmed K; Beksinska M; Serrano M; Bailey V; Masson L; Deese J
Am J Reprod Immunol; 2022 Aug; 88(2):e13542. PubMed ID: 35394678
[TBL] [Abstract][Full Text] [Related]
35. Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial.
Singata-Madliki M; Hofmeyr GJ; Carayon-Lefebvre d'Hellencourt F; Lawrie TA
BMJ Open; 2017 Nov; 7(11):e019205. PubMed ID: 29133336
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
[TBL] [Abstract][Full Text] [Related]
37. Androgen levels in women using a single implant of nomegestrol acetate.
Barbosa I; Coutinho E; Athayde C; Ladipo OA; Olsson SE; Ulmsten U
Contraception; 1996 Jan; 53(1):37-40. PubMed ID: 8631188
[TBL] [Abstract][Full Text] [Related]
38. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
[TBL] [Abstract][Full Text] [Related]
39. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
[TBL] [Abstract][Full Text] [Related]
40. New contraceptives in the 1990s.
O'Connell BJ
Curr Opin Pediatr; 1995 Aug; 7(4):371-5. PubMed ID: 7581638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
